ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1

CUSIP: 00484MAA4

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Debt / NOTE 1.750% 6/1
Market price (% of par)
103.74%
Total 13F principal
$310,542,902
Principal change
+$281,921,902
Total reported market value
$321,947,872
Number of holders
44
Value change
+$292,254,041
Number of buys
39
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 00484MAA4?
CUSIP 00484MAA4 identifies 00484MAA4 - ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 as of Q3 2014

As of 30 Sep 2014, ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 was held by 44 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $310,542,902 in principal (par value) of the bond. The largest 10 bondholders included BAKER BROS. ADVISORS LP, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, Fore Research & Management, LP, Calamos Advisors LLC, Davidson Kempner Capital Management LP, LINDEN ADVISORS LP, CAMDEN ASSET MANAGEMENT L P /CA, FMR LLC, PENN CAPITAL MANAGEMENT CO INC, and SYMPHONY ASSET MANAGEMENT LLC. This page lists 44 institutional bondholders reporting positions for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.